Abstract
Background Blood culture-based surveillance for typhoid fever has limited sensitivity, encountering operational challenges in resource-limited settings. Environmental surveillance targeting Salmonella Typhi (S. Typhi) shed in wastewater (WW), coupled with cross-sectional serosurveys of S. Typhi-specific antibodies estimating exposure to infection, emerges as a promising alternative.
Methods We assessed the feasibility and effectiveness of wastewater (WW) and sero-surveillance for S. Typhi in Vellore, India, from May 2022 to April 2023. Monthly samples were collected from 40 sites in open drainage channels and processed using standardized protocols. DNA was extracted and analyzed via quantitative PCR for S. Typhi genes (ttr, tviB, staG) and the fecal biomarker HF183. Clinical cases of enteric fever were recorded from four major hospitals, and a cross-sectional serosurvey measured hemolysin E (HlyE) IgG levels in children under 15 years to estimate seroincidence.
Results 7.5% (39/520) of grab and 15.3% (79/517) Moore swabs were positive for all 3 S . Typhi genes. Moore swab positivity was significantly associated with HF183 (adjusted odds ratio (aOR): 3.08, 95% CI: 1.59 – 5.93) and upstream catchment population (aOR: 4.67, 1.97 – 11.04), and there was increased detection during monsoon season - membrane filtration (aOR: 2.56, 1.02 – 6.41), and Moore swab samples (aOR: 2.03, 1.01 – 3.97).
Only 11 blood culture-confirmed typhoid cases were documented over the study period. Estimated seroincidence was 10.4/100 person-years (py) (95% CI: 9.61 - 11.5/100 py). The number of S. Typhi positive samples at a site was associated with the estimated sero-incidence in the site catchment population (incidence rate ratios: 1.14 (1.07-1.23) and 1.10 (1.02-1.20) for grab and Moore swabs respectively.
Conclusions These findings underscore the utility and effectiveness of alternate surveillance approaches to estimating the incidence of S. Typhi infection in resource-limited settings, offering valuable insights for public health interventions and disease monitoring strategies where conventional methods are challenging to implement.
Author Summary Our study explores the potential of detecting Salmonella Typhi in wastewater, informing public health strategies, guiding vaccination campaigns, and monitoring the effectiveness of interventions, contributing to better disease control and prevention policies.
S. Typhi positivity rates of 7.50% and 15.30% were observed in grab samples and Moore swabs, respectively, and significant correlations were found between S. Typhi positivity in Moore swabs and fecal contamination marker levels in wastewater samples.
The study also estimated that the community seroincidence for typhoid 10.40/100 person-years and S. Typhi detections in WW positively correlated with seroincidence.
The study reveals significant associations between wastewater S. Typhi positivity and typhoid seroincidence, seasonal variations, and population dynamics, providing deeper insights into the epidemiology of typhoid fever.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.protocols.io/workspaces/typhoides
Funding Statement
This work was supported by the Bill and Melinda Gates Foundation (grant number INV-002381); the Medical Research Council (MRC) Center for Global Infectious Disease Analysis (grant number MR/R015600/1), jointly funded by the UK MRC and the UK Foreign, Commonwealth, and Development Office (FCDO) under the MRC/FCDO Concordat agreement; and the EDCTP2 program supported by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Wastewater surveillance work has been approved by the Institutional Review Board of Christian Medical College, Vellore; CMC IRB Min No.11170. amended on 22 July 2020, IRB number A23, 22.07.2020. Community serosurvey for estimating the seroincidence of Typhoid was approved by the Institutional Review Board of Christian Medical College, Vellore; CMC IRB Min No.12973 (OBSERVE) dated 24 June 2020. Formal informed consent was obtained from the parent/guardian of all children for serosurvey, and written informed assent was obtained from children aged 11 to 15 years.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at https://github.com/drvenkatm/ES_Salmonella_Vellore-May22_Apr23.git
https://github.com/drvenkatm/ES_Salmonella_Vellore-May22_Apr23.git
